FCN3 and hepatoblastoma: Analysis of the results from the present study revealed a higher diagnostic and prognostic value of FCN3, and a previous transcriptomic and genomic analysis study showed that FCN3 showed a consistent reduction in expression in HCC and hepatoblastoma (HPBL) compared to normal liver tissue, consistent with the results validated in the present study (Luo et al., 2006).